Monopar Therapeutics (MNPR) income statement
MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$69.00−1.29 (-1.84%)
Close on Nov 20, 2026Market cap $463.14MP/E –Yield –
Monopar Therapeutics financial ratios
See a number that looks wrong?